Guardiani M, Tortellini E, Carraro A, Zingaropoli MA, et al. Long-Acting Cabotegravir/Rilpivirine Reduces Immune-Activation and -Senescence in People With HIV With CMV Co-Infection. Immunology 2026 Jun 16. doi: 10.1111/imm.70154.
PMID: 42300985